| CYP7B1 — Cytochrome P450 Family 7 Subfamily B Member 1 | |
|---|---|
| Symbol | CYP7B1 |
| Full Name | Cytochrome P450 7B1 (Oxysterol 7-alpha-hydroxylase) |
| Chromosome | 8q12.3 |
| NCBI Gene | 9420 |
| Ensembl | ENSG00000172817 |
| OMIM | 603711 |
| UniProt | O76074 |
| Protein | [CYP7B1 Protein](/proteins/cyp7b1-protein) |
| Diseases | [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia) (SPG5), [Liver Disease](/diseases/liver-disease) |
| Expression | Liver, Brain, Kidney, Testis, Spinal cord |
| KG Connections | 1 edges |
CYP7B1 — Cytochrome P450 7B1
Introduction
Cyp7B1 Gene Hereditary Spastic Paraplegia 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
flowchart TD
CYP7B1["CYP7B1"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
CYP7B1["CYP7B1"] -->|"activates"| Alzheimer["Alzheimer"]
CYP7B1["CYP7B1"] -->|"activates"| Tumor["Tumor"]
CYP7B1["CYP7B1"] -->|"therapeutic target"| TNF["TNF"]
CYP7B1["CYP7B1"] -->|"inhibits"| CYP46A1["CYP46A1"]
CYP7B1["CYP7B1"] -->|"activates"| TNF["TNF"]
CYP7B1["CYP7B1"] -->|"therapeutic target"| Rb["Rb"]
CYP7B1["CYP7B1"] -->|"therapeutic target"| GSH["GSH"]
CYP7B1["CYP7B1"] -->|"therapeutic target"| IL_6["IL-6"]
CYP7B1["CYP7B1"] -->|"therapeutic target"| Lipid_Metabolism["Lipid Metabolism"]
CYP7B1["CYP7B1"] -->|"inhibits"| Cholesterol["Cholesterol"]
CYP7B1["CYP7B1"] -->|"activates"| ROS["ROS"]
CYP7B1["CYP7B1"] -->|"activates"| IL_6["IL-6"]
CYP7B1["CYP7B1"] -->|"activates"| IL_17["IL-17"]
style CYP7B1 fill:#4fc3f7,stroke:#333,color:#000CYP7B1 (Cytochrome P450 Family 7 Subfamily B Member 1) encodes the enzyme oxysterol 7-alpha-hydroxylase, a crucial enzyme in cholesterol metabolism and bile acid synthesis [1]. Located on chromosome 8q12.3, mutations in CYP7B1 cause autosomal recessive hereditary spastic paraplegia type 5 (SPG5) and a form of congenital bile acid deficiency [2][3].
The enzyme catalyzes multiple hydroxylation reactions essential for cholesterol homeostasis:
-
7-alpha hydroxylation of cholesterol: First step in classic bile acid synthesis pathway
-
25-hydroxycholesterol metabolism: Important for oxysterol homeostasis
-
27-hydroxycholesterol metabolism: Key intermediate in alternative bile acid pathway
Function
Enzymatic Activity
CYP7B1 catalyzes the following reactions:
-
Cholesterol to 7-alpha-hydroxycholesterol: Rate-limiting step in bile acid synthesis
-
25-hydroxycholesterol to 7-alpha,25-dihydroxycholesterol: Oxysterol metabolism
-
27-hydroxycholesterol to 7-alpha,27-dihydroxycholesterol: Alternative pathway
Tissue Distribution
-
Liver: Primary site of expression, bile acid synthesis
-
Brain: Neurons and astrocytes, neurosteroid metabolism
-
Kidney: Steroid hormone metabolism
-
Testis: Testosterone metabolism
-
Spinal Cord: Motor neuron expression
Physiological Roles
-
Bile Acid Synthesis: Essential for converting cholesterol to bile acids
-
Cholesterol Homeostasis: Maintains systemic cholesterol balance
-
Neurosteroid Metabolism: Produces neuroactive steroids
-
Oxysterol Clearance: Metabolizes potentially toxic oxysterols
Disease Associations
SPG5 - Hereditary Spastic Paraplegia
CYP7B1 mutations cause autosomal recessive hereditary spastic paraplegia type 5 (SPG5) [2][3]:
-
Inheritance: Autosomal recessive
-
Onset: Usually childhood or adolescence
-
Clinical Features:
-
Progressive lower limb spasticity
-
Weakness and stiffness
-
Urinary urgency/incontinence
-
Mild peripheral neuropathy
-
-
Pathology: Degeneration of corticospinal tract fibers
-
Brain Imaging: May show white matter abnormalities
Bile Acid Deficiency
CYP7B1 mutations can cause:
-
Neonatal Cholestasis: Liver dysfunction in infancy
-
Fat Soluble Vitamin Deficiency: Due to impaired fat absorption
-
Progressive Family Liver Disease: May lead to cirrhosis
Molecular Mechanisms
Neurodegeneration
The mechanism of neurodegeneration in SPG5 involves:
-
Accumulation of 27-hydroxycholesterol: Toxic to neurons
-
Impaired neurosteroid synthesis: Reduced neuroprotective steroids
-
Oxysterol toxicity: Interferes with neuronal function
-
Mitochondrial dysfunction: Secondary energy impairment
Cholesterol Metabolism Defect
-
Accumulation of neurotoxic oxysterols
-
Impaired clearance of cholesterol derivatives
-
Disruption of lipid rafts in neuronal membranes
Therapeutic Approaches
| Approach | Mechanism | Status | Reference |
|---|---|---|---|
| Cholesterol-lowering agents | Reduce oxysterol burden | Symptomatic | [4] |
| Gene Therapy | Restore CYP7B1 expression | Preclinical | - |
| Bile Acid Supplementation | Bypass metabolic block | Research | - |
Animal Models
-
Cyp7b1 Knockout Mice: Show accumulation of 27-hydroxycholesterol
-
Motor Phenotype: Exhibit progressive motor deficits
-
Cholesterol Abnormalities: Elevated plasma cholesterol
See Also
Background
The study of Cyp7B1 Gene Hereditary Spastic Paraplegia 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.